Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer
© 2018 The Authors..
BACKGROUND AND PURPOSE: Organ motion is a challenge during high-precision external beam radiotherapy in cervical cancer, and improved strategies for treatment adaptation and monitoring of target dose coverage are needed. This study evaluates a cone beam computed tomography (CBCT)-based approach.
MATERIALS AND METHODS: In twenty-three patients, individualized internal target volumes (ITVs) were generated from pre-treatment MRI and CT scans with full and empty bladders. The target volumes encompassed high-risk clinical target volume (CTV-T HR) (gross tumor volume + remaining cervix) and low risk (LR) CTV-T (CTV-T HR + uterus + parametriae + upper vagina). Volumetric Modulated Arc Therapy (VMAT) was used to deliver a dose of 45 Gy in 25 fractions. CBCTs were used for setup and for radiation therapists (RTTs) to evaluate the target coverage (inside/outside the planning target volume). CBCTs were reviewed offline. Estimates of the dose delivered with minimum (point) doses across all fractions to CTV-T HR (aim 42.75 Gy) and CTV-T LR (aim 40 Gy) were assessed. In patients with insufficient dose coverage, re-plans were generated based on previous imaging.
RESULTS: Median (range) of the ITV-margins (mean of anterior-posterior margins) related to uterus and cervix was 1.2 (0.5-2.2 and 1.0-2.1) cm. RTTs were able to assess the target coverage in 90% of all CBCTs (505/563). With re-planning, one patient had considerable benefit (12.7 Gy increase of minimum dose) to CTV-T LR_vagina, four patients had improved dose to the CTV-T LR_uterus (1.2-1.8 Gy), and 3 patients did not benefit from re-planning.
CONCLUSIONS: Daily CBCT-based monitoring of target coverage by the RTTs has proven safe with limited workload. It allows for reduction in the treated volumes without compromising the target dose coverage.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2019 |
---|---|
Erschienen: |
2019 |
Enthalten in: |
Zur Gesamtaufnahme - volume:9 |
---|---|
Enthalten in: |
Physics and imaging in radiation oncology - 9(2019) vom: 24. Jan., Seite 14-20 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Jensen, Nina Boje Kibsgaard [VerfasserIn] |
---|
Links: |
---|
Themen: |
Adaptive radiotherapy |
---|
Anmerkungen: |
Date Revised 20.04.2022 published: Electronic-eCollection Citation Status PubMed-not-MEDLINE |
---|
doi: |
10.1016/j.phro.2018.12.002 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM320210308 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM320210308 | ||
003 | DE-627 | ||
005 | 20231225173106.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2019 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.phro.2018.12.002 |2 doi | |
028 | 5 | 2 | |a pubmed24n1067.xml |
035 | |a (DE-627)NLM320210308 | ||
035 | |a (NLM)33458421 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Jensen, Nina Boje Kibsgaard |e verfasserin |4 aut | |
245 | 1 | 0 | |a Cone beam computed tomography-based monitoring and management of target and organ motion during external beam radiotherapy in cervical cancer |
264 | 1 | |c 2019 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Revised 20.04.2022 | ||
500 | |a published: Electronic-eCollection | ||
500 | |a Citation Status PubMed-not-MEDLINE | ||
520 | |a © 2018 The Authors. | ||
520 | |a BACKGROUND AND PURPOSE: Organ motion is a challenge during high-precision external beam radiotherapy in cervical cancer, and improved strategies for treatment adaptation and monitoring of target dose coverage are needed. This study evaluates a cone beam computed tomography (CBCT)-based approach | ||
520 | |a MATERIALS AND METHODS: In twenty-three patients, individualized internal target volumes (ITVs) were generated from pre-treatment MRI and CT scans with full and empty bladders. The target volumes encompassed high-risk clinical target volume (CTV-T HR) (gross tumor volume + remaining cervix) and low risk (LR) CTV-T (CTV-T HR + uterus + parametriae + upper vagina). Volumetric Modulated Arc Therapy (VMAT) was used to deliver a dose of 45 Gy in 25 fractions. CBCTs were used for setup and for radiation therapists (RTTs) to evaluate the target coverage (inside/outside the planning target volume). CBCTs were reviewed offline. Estimates of the dose delivered with minimum (point) doses across all fractions to CTV-T HR (aim 42.75 Gy) and CTV-T LR (aim 40 Gy) were assessed. In patients with insufficient dose coverage, re-plans were generated based on previous imaging | ||
520 | |a RESULTS: Median (range) of the ITV-margins (mean of anterior-posterior margins) related to uterus and cervix was 1.2 (0.5-2.2 and 1.0-2.1) cm. RTTs were able to assess the target coverage in 90% of all CBCTs (505/563). With re-planning, one patient had considerable benefit (12.7 Gy increase of minimum dose) to CTV-T LR_vagina, four patients had improved dose to the CTV-T LR_uterus (1.2-1.8 Gy), and 3 patients did not benefit from re-planning | ||
520 | |a CONCLUSIONS: Daily CBCT-based monitoring of target coverage by the RTTs has proven safe with limited workload. It allows for reduction in the treated volumes without compromising the target dose coverage | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Adaptive radiotherapy | |
650 | 4 | |a Cervical cancer | |
650 | 4 | |a Cone-beam computed tomography | |
650 | 4 | |a External beam radiotherapy | |
650 | 4 | |a Image guidance | |
650 | 4 | |a Interfraction motion | |
700 | 1 | |a Assenholt, Marianne Sanggaard |e verfasserin |4 aut | |
700 | 1 | |a Fokdal, Lars Ulrik |e verfasserin |4 aut | |
700 | 1 | |a Vestergaard, Anne |e verfasserin |4 aut | |
700 | 1 | |a Schouboe, Annette |e verfasserin |4 aut | |
700 | 1 | |a Kjaersgaard, Eva Bruun |e verfasserin |4 aut | |
700 | 1 | |a Boejen, Annette |e verfasserin |4 aut | |
700 | 1 | |a Nyvang, Lars |e verfasserin |4 aut | |
700 | 1 | |a Lindegaard, Jacob Christian |e verfasserin |4 aut | |
700 | 1 | |a Tanderup, Kari |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Physics and imaging in radiation oncology |d 2017 |g 9(2019) vom: 24. Jan., Seite 14-20 |w (DE-627)NLM277257158 |x 2405-6316 |7 nnns |
773 | 1 | 8 | |g volume:9 |g year:2019 |g day:24 |g month:01 |g pages:14-20 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.phro.2018.12.002 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 9 |j 2019 |b 24 |c 01 |h 14-20 |